Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Osteoclast differentiation (mmu04380)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1500003O
03Rik
KLA  ATP  ATP+KLA
 NM_019769 RIKEN cDNA 1500003O03 gene (1500003O03Rik), mRNA [NM_019769] KLA .92 .89 .89 .86 .85 .92 1.08
ATP 1.01 1.16 1.16 1.53 1.70 3.33 2.09
KLA/ATP .89 .97 .93 1.17 1.19 2.86 2.57
2010110P
09Rik
KLA  ATP  ATP+KLA
 NM_027363 RIKEN cDNA 2010110P09 gene (2010110P09Rik), mRNA [NM_027363] KLA .99 .98 1.02 .99 .94 1.01 1.01
ATP 1.04 1.05 .97 1.05 .95 .98 .95
KLA/ATP .93 1.00 1.02 .97 1.01 .96 .97
Acp5
KLA  ATP  ATP+KLA
 NM_007388 acid phosphatase 5, tartrate resistant (Acp5), transcript variant 3, mRNA [NM_007388] KLA 3.62 3.55 3.27 3.26 3.31 3.93 5.79
ATP .96 1.00 1.29 1.96 2.30 3.05 3.81
KLA/ATP 3.61 3.85 4.05 5.38 4.56 5.15 6.77
AK036998
KLA  ATP  ATP+KLA
 AK036998 adult female vagina cDNA, RIKEN full-length enriched library, clone:9930034M05 product:unclassifiable, full insert sequence. [AK036998] KLA 1.43 1.09 .89 .79 .96 .97 .71
ATP 1.04 1.04 .71 .64 .90 .82 .82
KLA/ATP 1.34 1.23 1.01 .89 1.10 .82 .75
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
BB229853
KLA  ATP  ATP+KLA
 BB229853 gb|BB229853 RIKEN full-length enriched, 3 days neonate thymus Mus musculus cDNA clone A630023O21 3. [BB229853] KLA 6.32 5.94 6.13 6.41 7.39 12.33 6.08
ATP .39 .24 .33 .38 1.18 5.75 2.85
KLA/ATP 2.27 2.02 3.25 4.04 7.11 10.22 13.93
Blnk
KLA  ATP  ATP+KLA
 NM_008528 B-cell linker (Blnk), mRNA [NM_008528] KLA 1.53 1.39 1.23 1.31 1.01 1.41 1.21
ATP .95 .81 1.09 .87 2.09 1.28 .97
KLA/ATP 1.21 1.23 1.44 1.00 2.09 1.88 1.39
Btk
KLA  ATP  ATP+KLA
 NM_013482 Bruton agammaglobulinemia tyrosine kinase (Btk), mRNA [NM_013482] KLA 1.10 1.24 1.01 1.33 1.07 1.27 1.01
ATP .95 1.05 .86 .97 .66 .72 .82
KLA/ATP 1.14 1.35 1.12 1.52 .96 .70 .82
Calcr
KLA  ATP  ATP+KLA
 NM_007588 calcitonin receptor (Calcr), transcript variant a, mRNA [NM_007588] KLA .98 1.01 1.05 1.03 1.06 1.12 1.06
ATP .99 .97 1.01 1.05 1.00 1.00 1.02
KLA/ATP 1.02 1.02 .95 1.00 1.02 1.04 1.02
Camk4
KLA  ATP  ATP+KLA
 AK043457 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730097A20 product:CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE IV CATALYTIC CHAIN (EC 2.7.1.123) (CAM KINASE-GR) (CAMK IV) [CONTAINS: CALSPERMIN] homolog [Mus KLA .98 1.04 1.02 .93 1.03 1.07 1.07
ATP 1.01 .97 .97 1.10 1.00 .99 1.05
KLA/ATP 1.00 .96 1.02 .98 1.13 1.07 1.00
Camk4
KLA  ATP  ATP+KLA
 NM_009793 calcium/calmodulin-dependent protein kinase IV (Camk4), mRNA [NM_009793] KLA .96 1.02 1.01 1.02 1.03 1.07 1.08
ATP 1.01 1.03 1.07 1.08 .99 1.00 .99
KLA/ATP 1.01 .95 .98 1.08 1.12 1.02 1.03
Chuk
KLA  ATP  ATP+KLA
 NM_007700 conserved helix-loop-helix ubiquitous kinase (Chuk), mRNA [NM_007700] KLA 1.32 1.42 1.41 1.17 1.32 1.22 1.40
ATP 1.22 1.30 1.18 .97 1.02 1.00 1.37
KLA/ATP 1.56 1.61 1.21 1.09 .83 .84 1.17
Creb1
KLA  ATP  ATP+KLA
 NM_009952 cAMP responsive element binding protein 1 (Creb1), transcript variant B, mRNA [NM_009952] KLA 1.42 1.33 1.16 .99 .83 .97 .92
ATP .92 .91 1.18 1.38 1.51 1.02 .75
KLA/ATP 1.34 1.31 1.49 1.37 1.71 1.05 .93
Csf1
KLA  ATP  ATP+KLA
 NM_007778 colony stimulating factor 1 (macrophage) (Csf1), transcript variant 1, mRNA [NM_007778] KLA 18.44 16.94 15.74 12.71 7.63 6.20 2.51
ATP 1.04 1.22 4.90 14.80 12.10 10.26 6.73
KLA/ATP 16.93 18.17 20.56 19.41 18.03 15.99 12.59
Csf1r
KLA  ATP  ATP+KLA
 NM_001037859 colony stimulating factor 1 receptor (Csf1r), mRNA [NM_001037859] KLA .76 .81 .88 .67 .74 .78 .90
ATP 1.10 1.22 .88 1.10 .87 .78 1.28
KLA/ATP .97 .87 .63 .83 .51 .66 1.18
Ctsk
KLA  ATP  ATP+KLA
 NM_007802 cathepsin K (Ctsk), mRNA [NM_007802] KLA 1.02 1.14 1.16 1.37 1.40 1.95 2.05
ATP 1.04 1.06 1.34 2.32 3.59 8.92 14.36
KLA/ATP 1.08 1.23 1.62 2.29 4.63 15.04 24.14
Cyba
KLA  ATP  ATP+KLA
 NM_007806 cytochrome b-245, alpha polypeptide (Cyba), mRNA [NM_007806] KLA 1.02 1.05 1.06 .91 1.03 1.04 1.68
ATP 1.05 1.11 1.00 1.36 1.10 .95 1.21
KLA/ATP 1.03 1.11 .93 1.31 1.01 1.03 1.47
Cybb
KLA  ATP  ATP+KLA
 NM_007807 cytochrome b-245, beta polypeptide (Cybb), mRNA [NM_007807] KLA 5.43 5.43 5.59 5.19 5.71 5.00 5.08
ATP 1.08 1.18 1.19 1.64 1.68 2.73 1.82
KLA/ATP 5.34 5.62 4.98 6.75 3.74 3.36 3.96
Cyld
KLA  ATP  ATP+KLA
 AK147204 15 days pregnant adult female placenta cDNA, RIKEN full-length enriched library, clone:M421001K23 product:cylindromatosis (turban tumor syndrome), full insert sequence [AK147204] KLA .85 .83 .73 .65 .62 .61 .48
ATP .88 .79 .69 .47 .44 .43 .21
KLA/ATP .75 .66 .63 .42 .57 .41 .21
Cyld
KLA  ATP  ATP+KLA
 NM_173369 cylindromatosis (turban tumor syndrome) (Cyld), mRNA [NM_173369] KLA 1.64 1.65 1.53 1.74 1.66 1.46 1.30
ATP 1.05 1.14 1.04 .84 .75 .96 1.00
KLA/ATP 1.60 1.77 1.64 1.22 .93 1.00 1.28
EG232801
KLA  ATP  ATP+KLA
 NM_001081239 predicted gene, EG232801 (EG232801), mRNA [NM_001081239] KLA 1.01 1.01 1.00 .96 1.03 1.02 .99
ATP .97 1.00 .97 1.01 .99 1.01 1.02
KLA/ATP .99 1.01 .94 1.02 .98 1.02 1.01
Fcgr1
KLA  ATP  ATP+KLA
 AF143181 strain AB/H (Biozzi) high affinity immunoglobulin gamma Fc receptor I (Fcgr1) mRNA, Fcgr1-d allele, complete cds. [AF143181] KLA 4.27 4.21 5.59 6.14 8.13 9.76 10.98
ATP 1.23 1.12 1.08 1.36 1.09 2.09 11.81
KLA/ATP 4.56 4.93 4.95 5.88 6.66 9.64 23.09
Fcgr1
KLA  ATP  ATP+KLA
 NM_010186 Fc receptor, IgG, high affinity I (Fcgr1), mRNA [NM_010186] KLA 4.31 4.37 4.70 5.97 6.59 10.06 8.67
ATP 1.01 .88 1.16 .89 .90 2.15 9.23
KLA/ATP 4.01 4.10 5.52 4.54 6.31 9.24 15.83
Fcgr2b
KLA  ATP  ATP+KLA
 NM_001077189 Fc receptor, IgG, low affinity IIb (Fcgr2b), transcript variant 1, mRNA [NM_001077189] KLA 16.93 17.57 21.75 27.43 34.13 31.88 5.70
ATP 1.11 1.09 1.17 1.46 2.81 11.26 1.92
KLA/ATP 16.51 17.91 23.67 29.22 22.67 25.33 9.54
Fcgr2b
KLA  ATP  ATP+KLA
 NM_010187 Fc receptor, IgG, low affinity IIb (Fcgr2b), transcript variant 2, mRNA [NM_010187] KLA 11.41 11.67 14.06 15.47 17.28 18.63 4.69
ATP 1.05 1.06 1.18 1.57 2.27 8.97 2.10
KLA/ATP 10.98 12.01 15.03 18.38 15.15 16.00 8.33
Fcgr3
KLA  ATP  ATP+KLA
 NM_010188 Fc receptor, IgG, low affinity III (Fcgr3), mRNA [NM_010188] KLA 1.35 1.47 1.87 1.77 2.39 2.34 1.13
ATP 1.04 1.10 .99 1.14 1.01 1.55 1.90
KLA/ATP 1.50 1.53 1.53 1.99 1.61 2.38 2.69
Fcgr4
KLA  ATP  ATP+KLA
 NM_144559 Fc receptor, IgG, low affinity IV (Fcgr4), mRNA [NM_144559] KLA 9.03 8.68 9.82 11.51 11.12 13.01 7.95
ATP 1.04 .95 1.22 1.43 1.17 2.80 4.48
KLA/ATP 8.63 8.84 11.99 11.84 12.40 13.56 12.31
Fhl2
KLA  ATP  ATP+KLA
 AK081770 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130075G22 product:unclassifiable, full insert sequence [AK081770] KLA 1.00 1.00 .97 1.00 .96 .97 1.01
ATP 1.01 .95 .98 1.02 .98 1.06 1.06
KLA/ATP 1.00 .97 .99 .99 .99 1.00 .99
Fhl2
KLA  ATP  ATP+KLA
 NM_010212 four and a half LIM domains 2 (Fhl2), mRNA [NM_010212] KLA .97 1.02 .96 1.02 1.13 1.01 .89
ATP .96 1.00 1.05 .91 .94 .82 .89
KLA/ATP .97 1.04 1.03 .89 .94 .87 .95
Fos
KLA  ATP  ATP+KLA
 NM_010234 FBJ osteosarcoma oncogene (Fos), mRNA [NM_010234] KLA .42 .33 .64 .61 .71 .85 .71
ATP 3.48 5.46 23.78 25.22 1.71 2.36 1.50
KLA/ATP .90 1.74 5.97 8.62 1.28 2.42 4.52
Fosb
KLA  ATP  ATP+KLA
 NM_008036 FBJ osteosarcoma oncogene B (Fosb), mRNA [NM_008036] KLA .99 .88 .61 1.01 .74 1.03 1.00
ATP 8.75 11.87 14.21 15.92 11.71 3.22 1.29
KLA/ATP 3.13 5.07 3.50 7.61 4.95 3.70 1.87
Fosl1
KLA  ATP  ATP+KLA
 NM_010235 fos-like antigen 1 (Fosl1), mRNA [NM_010235] KLA .75 .72 .50 .55 .87 .97 1.29
ATP 1.00 .99 .72 1.57 7.76 9.10 2.11
KLA/ATP .83 .75 .53 .65 1.53 3.70 3.26
Fosl2
KLA  ATP  ATP+KLA
 NM_008037 fos-like antigen 2 (Fosl2), mRNA [NM_008037] KLA 1.25 1.36 1.47 1.78 1.89 1.09 1.26
ATP 1.02 1.33 2.29 3.65 3.11 3.65 1.52
KLA/ATP 1.22 1.46 1.84 3.23 3.18 2.73 2.17
Fyn
KLA  ATP  ATP+KLA
 U70324 Fyn(T) (L-fyn(T)) mRNA, complete cds. [U70324] KLA 1.23 1.27 1.31 1.27 1.31 .87 .48
ATP .88 .71 .66 .75 .90 1.28 .51
KLA/ATP 1.12 1.01 .94 .84 1.25 1.51 .53
Gab2
KLA  ATP  ATP+KLA
 NM_010248 growth factor receptor bound protein 2-associated protein 2 (Gab2), mRNA [NM_010248] KLA 1.01 1.04 1.04 1.02 1.12 1.16 1.14
ATP 1.02 1.06 1.00 1.13 1.16 1.19 1.23
KLA/ATP 1.06 1.05 1.03 1.02 1.03 1.04 1.29
Grb2
KLA  ATP  ATP+KLA
 NM_008163 growth factor receptor bound protein 2 (Grb2), mRNA [NM_008163] KLA .92 .88 .90 1.27 1.43 1.22 1.00
ATP 1.02 .83 .51 .42 .92 .70 .57
KLA/ATP .84 .77 .61 .56 1.56 1.49 .52
Grb2
KLA  ATP  ATP+KLA
 U07617 Grb2 adaptor protein (grb2) mRNA, complete cds. [U07617] KLA .83 .80 .95 1.13 1.38 1.36 1.06
ATP .84 .74 .51 .41 .82 .74 .59
KLA/ATP .77 .70 .57 .54 1.49 1.39 .53
Ifnar1
KLA  ATP  ATP+KLA
 NM_010508 interferon (alpha and beta) receptor 1 (Ifnar1), mRNA [NM_010508] KLA 1.35 1.29 1.19 1.39 1.60 1.47 1.49
ATP 1.18 1.25 .94 1.06 1.07 1.48 1.52
KLA/ATP 1.56 1.57 .98 1.43 1.08 1.79 3.54
Ifnar2
KLA  ATP  ATP+KLA
 NM_010509 interferon (alpha and beta) receptor 2 (Ifnar2), transcript variant 1, mRNA [NM_010509] KLA 1.45 1.43 1.67 1.87 2.31 1.84 1.36
ATP .99 .92 .87 1.03 1.38 1.79 1.43
KLA/ATP 1.48 1.48 1.24 1.54 1.77 2.10 2.81
Ifnb1
KLA  ATP  ATP+KLA
 NM_010510 interferon beta 1, fibroblast (Ifnb1), mRNA [NM_010510] KLA 49.82 46.57 34.05 16.05 5.94 7.31 8.49
ATP .99 1.02 1.89 4.78 6.31 4.44 1.79
KLA/ATP 49.22 61.83 134.08 144.05 110.96 31.78 11.24
Ifng
KLA  ATP  ATP+KLA
 NM_008337 interferon gamma (Ifng), mRNA [NM_008337] KLA 1.05 1.02 1.01 1.01 1.01 1.04 1.00
ATP 1.00 1.01 1.01 .98 .97 1.04 1.03
KLA/ATP 1.01 1.01 1.06 1.10 1.24 1.10 1.04
Ifngr1
KLA  ATP  ATP+KLA
 NM_010511 interferon gamma receptor 1 (Ifngr1), mRNA [NM_010511] KLA .81 .60 .37 .35 .34 .39 .54
ATP 1.05 .96 1.15 .97 .80 .67 .45
KLA/ATP .57 .57 .63 .36 .28 .33 .36
Ifngr2
KLA  ATP  ATP+KLA
 NM_008338 interferon gamma receptor 2 (Ifngr2), mRNA [NM_008338] KLA 1.45 1.49 1.74 2.22 3.22 2.42 1.96
ATP 1.11 1.03 .81 .78 1.12 1.28 1.34
KLA/ATP 1.48 1.41 1.17 1.23 1.48 1.89 2.13
Ikbkb
KLA  ATP  ATP+KLA
 NM_010546 inhibitor of kappaB kinase beta (Ikbkb), mRNA [NM_010546] KLA 1.88 2.10 2.14 1.83 1.73 1.31 1.19
ATP .81 .74 .55 .49 .59 1.05 .96
KLA/ATP 1.86 1.73 1.39 1.12 .89 1.17 1.24
Ikbkg
KLA  ATP  ATP+KLA
 AK042138 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630062P04 product:unclassifiable, full insert sequence. [AK042138] KLA .92 .87 .78 .78 .87 .88 .62
ATP .84 .71 .80 .50 1.15 2.33 .61
KLA/ATP .72 .69 .74 .48 1.06 1.97 .68
Ikbkg
KLA  ATP  ATP+KLA
 NM_010547 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 1, mRNA [NM_010547] KLA 1.51 1.63 1.74 1.83 1.83 1.73 1.72
ATP .80 .79 .82 .75 .66 2.58 2.37
KLA/ATP 1.43 1.42 1.17 1.04 .71 1.54 3.17
Ikbkg
KLA  ATP  ATP+KLA
 NM_178590 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 2, mRNA [NM_178590] KLA .84 .93 .86 .91 1.03 .89 .88
ATP 1.03 .98 .68 .56 .51 .93 .68
KLA/ATP .89 .81 .55 .52 .41 .67 .65
Il1a
KLA  ATP  ATP+KLA
 NM_010554 interleukin 1 alpha (Il1a), mRNA [NM_010554] KLA 32.45 35.22 31.30 20.95 28.57 18.36 19.02
ATP 1.04 1.02 2.21 5.46 11.06 32.07 3.40
KLA/ATP 32.02 41.20 35.12 46.91 28.76 42.72 57.80
Il1b
KLA  ATP  ATP+KLA
 NM_008361 interleukin 1 beta (Il1b), mRNA [NM_008361] KLA 149.78 133.59 100.91 116.58 86.48 89.37 64.72
ATP 3.49 13.96 61.44 70.91 82.12 162.79 28.18
KLA/ATP 130.32 139.00 219.12 148.17 165.44 172.57 146.98
Il1r1
KLA  ATP  ATP+KLA
 NM_008362 interleukin 1 receptor, type I (Il1r1), transcript variant 1, mRNA [NM_008362] KLA 1.20 1.08 1.22 1.52 2.19 2.32 1.61
ATP 1.10 .96 1.18 1.56 8.14 9.56 7.54
KLA/ATP 1.22 1.13 1.37 1.85 4.54 6.85 8.96
Irf9
KLA  ATP  ATP+KLA
 NM_008394 interferon regulatory factor 9 (Irf9), mRNA [NM_008394] KLA 1.96 1.99 2.13 1.83 1.81 1.85 1.71
ATP 1.08 1.06 .96 1.19 1.21 2.33 2.42
KLA/ATP 2.31 2.30 1.92 2.85 2.29 3.20 4.37
Itgb3
KLA  ATP  ATP+KLA
 AF026509 integrin beta3 subunit mRNA, complete cds. [AF026509] KLA 2.38 2.64 2.65 3.15 4.02 4.46 2.83
ATP 1.21 1.17 1.25 1.62 2.33 3.09 4.78
KLA/ATP 2.48 2.63 3.39 3.72 4.30 4.71 6.79
Itgb3
KLA  ATP  ATP+KLA
 NM_016780 integrin beta 3 (Itgb3), mRNA [NM_016780] KLA .50 .51 .52 .41 .31 .25 .15
ATP .94 .88 1.17 .89 .99 1.36 .91
KLA/ATP .51 .54 .67 .52 .61 .74 .48
Jak1
KLA  ATP  ATP+KLA
 AK029232 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831433J01 product:Janus kinase 1, full insert sequence. [AK029232] KLA 1.25 1.13 1.19 1.31 1.24 1.17 1.14
ATP 1.01 1.11 .96 1.38 1.06 1.26 1.05
KLA/ATP 1.19 1.29 1.27 1.59 1.18 1.38 1.24
Jak1
KLA  ATP  ATP+KLA
 NM_146145 Janus kinase 1 (Jak1), mRNA [NM_146145] KLA 1.71 1.75 1.79 1.81 1.72 1.37 1.21
ATP 1.03 1.01 .75 1.04 1.32 1.90 1.14
KLA/ATP 1.84 1.73 1.49 2.07 2.01 1.83 1.68
Jun
KLA  ATP  ATP+KLA
 NM_010591 Jun oncogene (Jun), mRNA [NM_010591] KLA 1.08 .96 1.09 1.09 .75 .88 .81
ATP 1.26 1.48 4.45 8.73 4.02 1.16 1.99
KLA/ATP 1.12 1.38 3.52 5.17 3.32 .49 1.42
Junb
KLA  ATP  ATP+KLA
 NM_008416 Jun-B oncogene (Junb), mRNA [NM_008416] KLA 4.71 4.37 4.30 4.98 4.85 3.70 3.53
ATP 2.20 3.40 11.86 19.56 9.63 5.04 1.94
KLA/ATP 5.09 6.66 11.69 20.90 17.53 7.06 6.21
Jund
KLA  ATP  ATP+KLA
 NM_010592 Jun proto-oncogene related gene d (Jund), mRNA [NM_010592] KLA 1.56 1.42 1.33 1.15 1.00 .95 1.36
ATP 1.21 1.51 3.47 5.90 5.16 1.99 1.13
KLA/ATP 1.58 1.80 2.28 4.01 4.07 2.47 1.35
Lck
KLA  ATP  ATP+KLA
 NM_010693 lymphocyte protein tyrosine kinase (Lck), mRNA [NM_010693] KLA 18.74 17.97 23.64 20.20 17.34 8.29 1.29
ATP 1.00 1.04 1.28 1.30 1.48 2.55 1.44
KLA/ATP 21.76 24.22 23.73 23.04 22.66 12.06 2.90
Lcp2
KLA  ATP  ATP+KLA
 NM_010696 lymphocyte cytosolic protein 2 (Lcp2), mRNA [NM_010696] KLA 9.10 9.37 9.29 7.53 9.33 5.54 4.23
ATP 1.25 1.38 .95 1.73 2.80 2.13 1.06
KLA/ATP 10.47 10.89 6.89 11.38 3.88 1.80 2.82
Lilrb3
KLA  ATP  ATP+KLA
 NM_011095 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 (Lilrb3), mRNA [NM_011095] KLA 1.72 1.76 1.91 2.57 2.60 2.82 2.30
ATP .95 .85 .82 .58 .78 1.38 1.77
KLA/ATP 1.49 1.42 1.52 1.10 1.16 1.39 2.84
Map2k1
KLA  ATP  ATP+KLA
 NM_008927 mitogen-activated protein kinase kinase 1 (Map2k1), mRNA [NM_008927] KLA 1.82 2.00 2.31 2.03 2.51 2.20 1.51
ATP .99 1.14 .81 .87 .90 1.57 1.11
KLA/ATP 1.90 2.03 1.50 1.93 1.63 2.03 2.06
Map2k6
KLA  ATP  ATP+KLA
 NM_011943 mitogen-activated protein kinase kinase 6 (Map2k6), mRNA [NM_011943] KLA .68 .67 .64 .67 .62 .59 .61
ATP 1.02 1.12 1.04 1.10 .79 .61 .61
KLA/ATP .73 .69 .71 .74 .66 .62 .98
Map2k7
KLA  ATP  ATP+KLA
 BC070467 mitogen activated protein kinase kinase 7, mRNA (cDNA clone MGC:96654 IMAGE:30615302), complete cds [BC070467] KLA .77 .79 .88 .77 .97 .96 1.27
ATP 1.11 1.26 .93 1.19 1.13 1.45 1.16
KLA/ATP .89 .88 .59 .89 .86 1.32 1.28
Map2k7
KLA  ATP  ATP+KLA
 NM_001042557 mitogen-activated protein kinase kinase 7 (Map2k7), transcript variant 1, mRNA [NM_001042557] KLA .96 .95 1.02 .96 .95 1.09 1.19
ATP 1.02 1.07 .88 .97 .93 1.10 1.17
KLA/ATP 1.01 .99 .80 .87 .76 1.21 1.16
Map3k14
KLA  ATP  ATP+KLA
 NM_016896 mitogen-activated protein kinase kinase kinase 14 (Map3k14), mRNA [NM_016896] KLA .32 .30 .40 .52 1.08 1.14 .94
ATP 1.18 1.24 1.13 .85 .82 .84 .99
KLA/ATP .33 .30 .34 .50 1.02 .84 1.43
Map3k7
KLA  ATP  ATP+KLA
 NM_172688 mitogen-activated protein kinase kinase kinase 7 (Map3k7), mRNA [NM_172688] KLA 1.48 1.49 1.51 1.24 1.21 1.19 1.61
ATP 1.10 1.16 1.03 1.03 1.12 1.61 1.61
KLA/ATP 1.43 1.56 1.05 1.15 .85 1.48 1.76
Map3k7ip
1
KLA  ATP  ATP+KLA
 NM_025609 mitogen-activated protein kinase kinase kinase 7 interacting protein 1 (Map3k7ip1), mRNA [NM_025609] KLA .32 .30 .35 .56 .67 .82 .76
ATP .95 .81 .80 .42 .35 .40 .80
KLA/ATP .33 .30 .37 .20 .45 .62 .65
Map3k7ip
2
KLA  ATP  ATP+KLA
 AK086230 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930015C19 product:inferred: Mus musculus, Similar to TAK1-binding protein 2; KIAA0733 protein, clone MGC:8010 IMAGE:3586132, mRNA, complete cds, full insert sequence. [A KLA 1.14 1.02 1.07 1.03 1.13 1.02 .96
ATP 1.00 .88 .92 .90 1.06 .96 .94
KLA/ATP 1.05 1.00 .90 .98 1.02 .97 .97
Map3k7ip
2
KLA  ATP  ATP+KLA
 NM_138667 mitogen-activated protein kinase kinase kinase 7 interacting protein 2 (Map3k7ip2), mRNA [NM_138667] KLA 3.43 3.22 3.19 2.41 2.13 1.51 1.10
ATP 1.08 1.08 .86 .81 1.30 1.32 1.02
KLA/ATP 3.34 3.66 3.00 2.58 1.80 1.52 1.61
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk10
KLA  ATP  ATP+KLA
 AK076990 adult male testis cDNA, RIKEN full-length enriched library, clone:4930597C01 product:mitogen activated protein kinase 10, full insert sequence. [AK076990] KLA 1.03 1.05 .98 1.04 .94 .95 1.02
ATP 1.00 .99 1.06 .97 1.01 .96 .99
KLA/ATP 1.07 1.01 .95 1.05 .82 .95 .87
Mapk10
KLA  ATP  ATP+KLA
 NM_009158 mitogen-activated protein kinase 10 (Mapk10), transcript variant 1, mRNA [NM_009158] KLA .95 1.00 .97 1.01 .99 1.01 .95
ATP 1.01 1.02 .98 1.01 1.04 1.01 .99
KLA/ATP 1.05 .99 1.01 .98 .92 .97 .98
Mapk11
KLA  ATP  ATP+KLA
 NM_011161 mitogen-activated protein kinase 11 (Mapk11), mRNA [NM_011161] KLA 1.28 1.30 1.41 1.46 1.58 1.29 .98
ATP .96 .95 .89 .82 .79 1.09 .85
KLA/ATP 1.44 1.42 1.32 1.23 1.23 .74 .66
Mapk12
KLA  ATP  ATP+KLA
 NM_013871 mitogen-activated protein kinase 12 (Mapk12), mRNA [NM_013871] KLA .94 .86 .87 .81 .77 .68 .49
ATP .97 .83 .92 .90 .86 .90 .51
KLA/ATP .91 .89 .88 .85 1.12 1.14 .53
Mapk13
KLA  ATP  ATP+KLA
 NM_011950 mitogen-activated protein kinase 13 (Mapk13), mRNA [NM_011950] KLA 1.22 1.21 1.35 1.26 1.24 1.13 1.01
ATP 1.08 1.00 1.20 1.20 1.13 1.22 1.39
KLA/ATP 1.22 1.27 1.30 1.30 1.21 1.11 1.47
Mapk14
KLA  ATP  ATP+KLA
 NM_011951 mitogen-activated protein kinase 14 (Mapk14), mRNA [NM_011951] KLA .70 .70 .62 .54 .67 .88 1.11
ATP 1.03 .98 .87 .69 .48 .78 .66
KLA/ATP .74 .68 .52 .46 .38 .45 .62
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mapk8
KLA  ATP  ATP+KLA
 AK162915 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330031O19 product:mitogen activated protein kinase 8, full insert sequence [AK162915] KLA .94 .86 .80 .83 .77 .85 .83
ATP 1.08 1.12 .94 .80 .83 .71 .75
KLA/ATP .83 .81 .80 .74 .74 .75 .67
Mapk8
KLA  ATP  ATP+KLA
 AK163829 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130070A06 product:mitogen activated protein kinase 8, full insert sequence [AK163829] KLA .65 .61 .66 .70 .90 1.02 1.03
ATP .99 .94 1.68 1.44 1.75 1.84 1.10
KLA/ATP .63 .67 1.11 1.00 2.01 1.68 1.15
Mapk8
KLA  ATP  ATP+KLA
 NM_016700 mitogen-activated protein kinase 8 (Mapk8), mRNA [NM_016700] KLA .96 1.00 .94 .96 .94 .99 1.04
ATP 1.01 1.05 1.01 .99 1.03 .98 1.02
KLA/ATP .96 .97 .96 .97 .93 .94 .96
Mapk9
KLA  ATP  ATP+KLA
 NM_016961 mitogen-activated protein kinase 9 (Mapk9), transcript variant 2, mRNA [NM_016961] KLA 1.28 1.37 1.59 1.60 1.61 1.43 1.38
ATP 1.03 .99 .74 .71 .79 1.20 1.01
KLA/ATP 1.53 1.30 1.07 .99 .83 1.10 1.40
Mapk9
KLA  ATP  ATP+KLA
 NM_207692 mitogen-activated protein kinase 9 (Mapk9), transcript variant 1, mRNA [NM_207692] KLA 1.39 1.53 1.69 1.69 1.55 1.44 1.51
ATP .95 .92 .75 .85 .70 1.46 1.17
KLA/ATP 1.37 1.35 .99 1.18 .91 1.22 1.62
Mitf
KLA  ATP  ATP+KLA
 NM_008601 microphthalmia-associated transcription factor (Mitf), transcript variant 2, mRNA [NM_008601] KLA 2.09 2.20 1.58 2.38 2.33 2.27 1.52
ATP .93 .99 1.15 1.87 1.18 .89 1.16
KLA/ATP 1.83 2.28 2.35 2.87 1.26 .81 1.63
Mm.15898
1
KLA  ATP  ATP+KLA
 142388182 Unknown KLA .25 .22 .31 .50 .85 1.11 .83
ATP 1.02 .94 1.31 .76 .73 .96 .92
KLA/ATP .24 .22 .34 .38 1.16 .96 1.23
Mm.1741
KLA  ATP  ATP+KLA
 31982052 Unknown KLA 4.05 3.90 3.12 3.55 4.00 3.37 2.25
ATP 1.01 1.01 1.44 2.36 3.07 3.54 1.27
KLA/ATP 4.19 3.74 4.02 4.02 3.13 2.82 3.33
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.24833
5
KLA  ATP  ATP+KLA
 110350004 Unknown KLA .83 .79 .63 .93 .75 1.10 1.03
ATP 10.10 12.76 17.13 18.61 13.01 3.37 1.36
KLA/ATP 3.05 5.96 4.94 8.73 5.80 4.08 1.91
Mm.24936
4
KLA  ATP  ATP+KLA
 133892283 Unknown KLA 1.42 1.41 1.61 2.14 2.88 2.49 2.03
ATP .98 .98 .76 .77 1.09 1.23 1.28
KLA/ATP 1.32 1.32 1.07 1.12 1.38 1.85 1.95
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.25806
1
KLA  ATP  ATP+KLA
 156766060 Unknown KLA 1.08 .96 1.05 .97 1.01 1.05 .88
ATP .94 1.00 .99 .97 .99 1.02 1.02
KLA/ATP 1.00 1.01 .95 1.00 .95 .98 1.01
Mm.27970
KLA  ATP  ATP+KLA
 13994135 Unknown KLA 1.06 1.11 1.16 1.07 1.11 1.08 .95
ATP 1.02 1.09 1.05 1.05 .94 1.16 1.32
KLA/ATP 1.10 1.19 1.11 1.04 1.08 1.02 1.33
Mm.32653
1
KLA  ATP  ATP+KLA
 6679332 Unknown KLA 1.26 1.23 1.50 1.57 1.97 2.07 1.91
ATP .99 1.06 .80 .92 .91 1.19 2.08
KLA/ATP 1.28 1.26 1.00 1.26 .89 1.17 2.90
Mm.33138
9
KLA  ATP  ATP+KLA
 158508469 Unknown KLA .80 .79 .81 .82 .72 .64 .50
ATP .95 .85 .56 .48 .30 .33 .46
KLA/ATP .71 .64 .50 .41 .33 .32 .42
Mm.42529
6
KLA  ATP  ATP+KLA
 170172552 Unknown KLA 1.51 1.59 1.64 1.57 1.87 1.40 1.91
ATP 1.02 1.04 .77 .91 .52 .49 1.04
KLA/ATP 1.63 1.53 1.11 1.32 .80 .69 1.23
Mm.45876
9
KLA  ATP  ATP+KLA
 6755063 Unknown KLA .99 .91 .94 .94 .97 1.03 1.32
ATP .95 .99 1.10 1.09 1.22 1.16 1.94
KLA/ATP .91 .90 .86 .93 .89 .68 1.80
Mm.46002
4
KLA  ATP  ATP+KLA
 38348245 Unknown KLA 1.22 1.25 1.25 1.19 1.22 1.47 1.14
ATP 1.03 .94 1.01 1.01 2.67 2.31 1.37
KLA/ATP 1.35 1.19 1.27 1.22 1.99 1.83 1.45
Ncf1
KLA  ATP  ATP+KLA
 NM_010876 neutrophil cytosolic factor 1 (Ncf1), mRNA [NM_010876] KLA 1.62 1.71 1.81 1.70 1.99 1.64 2.07
ATP 1.02 1.06 .78 1.02 .64 .56 1.08
KLA/ATP 1.87 1.81 1.22 1.73 1.00 .80 1.49
Ncf2
KLA  ATP  ATP+KLA
 NM_010877 neutrophil cytosolic factor 2 (Ncf2), mRNA [NM_010877] KLA .74 .69 .81 .83 1.07 1.20 .89
ATP 1.21 1.13 .91 1.00 .91 1.82 1.19
KLA/ATP .80 .74 .62 .70 .71 1.26 1.27
Ncf4
KLA  ATP  ATP+KLA
 NM_008677 neutrophil cytosolic factor 4 (Ncf4), mRNA [NM_008677] KLA 1.23 1.30 1.19 1.45 1.88 2.46 2.29
ATP .97 .83 .83 .87 1.25 1.99 3.67
KLA/ATP 1.21 1.11 1.04 1.13 1.48 1.70 2.60
Nfatc1
KLA  ATP  ATP+KLA
 NM_016791 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (Nfatc1), transcript variant 1, mRNA [NM_016791] KLA .71 .66 .68 .62 .63 .67 .81
ATP 1.12 1.29 1.15 1.21 .83 .63 1.25
KLA/ATP .78 .79 .65 .74 .59 .45 .92
Nfatc1
KLA  ATP  ATP+KLA
 NM_198429 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (Nfatc1), transcript variant 2, mRNA [NM_198429] KLA .49 .41 .50 .43 .50 .78 .69
ATP 1.05 .81 .84 .54 .60 .38 .69
KLA/ATP .46 .37 .45 .32 .62 .39 .61
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nfkb2
KLA  ATP  ATP+KLA
 NM_019408 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 (Nfkb2), mRNA [NM_019408] KLA 7.31 7.92 7.95 6.42 6.41 4.42 2.81
ATP .99 .98 .72 1.48 2.80 5.31 1.44
KLA/ATP 8.25 7.93 6.51 7.68 5.08 4.38 4.86
Nfkbia
KLA  ATP  ATP+KLA
 NM_010907 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia), mRNA [NM_010907] KLA 18.65 18.46 13.63 17.88 14.25 9.17 7.92
ATP .91 1.09 7.11 32.39 17.44 10.49 1.72
KLA/ATP 15.57 17.66 15.73 23.91 13.83 10.73 9.48
Nox1
KLA  ATP  ATP+KLA
 NM_172203 NADPH oxidase 1 (Nox1), mRNA [NM_172203] KLA 2.18 2.93 3.44 2.51 2.84 1.77 1.10
ATP 1.01 .99 1.13 1.21 1.09 1.00 1.03
KLA/ATP 3.07 3.07 1.88 2.30 1.55 1.60 1.14
Nox3
KLA  ATP  ATP+KLA
 NM_198958 NADPH oxidase 3 (Nox3), mRNA [NM_198958] KLA .98 .99 1.01 1.00 1.01 1.07 1.04
ATP 1.04 .95 .95 .96 1.02 .97 .92
KLA/ATP .99 1.03 .93 .99 .93 .95 .99
Oscar
KLA  ATP  ATP+KLA
 NM_175632 osteoclast associated receptor (Oscar), mRNA [NM_175632] KLA 1.03 1.03 1.13 1.08 1.06 1.12 1.15
ATP .97 .98 1.04 .97 .96 1.06 1.07
KLA/ATP 1.02 1.08 1.10 1.10 1.10 1.05 1.10
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Pira2
KLA  ATP  ATP+KLA
 NM_011089 paired-Ig-like receptor A2 (Pira2), mRNA [NM_011089] KLA 1.01 .97 .99 1.15 .99 1.07 1.22
ATP .92 .83 1.18 1.13 1.24 1.32 1.67
KLA/ATP .84 .85 1.03 1.01 1.01 .75 1.62
Pira3
KLA  ATP  ATP+KLA
 NM_011090 paired-Ig-like receptor A3 (Pira3), mRNA [NM_011090] KLA 1.14 1.10 1.21 1.32 1.45 1.45 1.42
ATP 1.05 1.11 .96 .98 1.02 1.31 1.98
KLA/ATP 1.11 1.13 1.08 1.22 .87 .94 2.39
Pira6
KLA  ATP  ATP+KLA
 NM_011093 paired-Ig-like receptor A6 (Pira6), transcript variant 2, mRNA [NM_011093] KLA 1.38 1.43 1.71 1.68 1.92 1.94 1.59
ATP 1.04 1.09 1.00 1.25 1.13 1.21 2.06
KLA/ATP 1.53 1.45 1.22 1.73 1.11 1.19 2.49
Plcg2
KLA  ATP  ATP+KLA
 NM_172285 phospholipase C, gamma 2 (Plcg2), mRNA [NM_172285] KLA .76 .74 .68 .66 .71 .92 .95
ATP .96 .90 .95 .87 .81 .79 .91
KLA/ATP .76 .71 .69 .62 .72 .78 .68
Pparg
KLA  ATP  ATP+KLA
 NM_011146 peroxisome proliferator activated receptor gamma (Pparg), mRNA [NM_011146] KLA .32 .28 .31 .45 .38 .35 .49
ATP .96 1.01 1.28 1.65 1.83 .57 .77
KLA/ATP .30 .29 .36 .53 1.23 .72 .55
Ppp3ca
KLA  ATP  ATP+KLA
 NM_008913 protein phosphatase 3, catalytic subunit, alpha isoform (Ppp3ca), mRNA [NM_008913] KLA .76 .85 .81 .85 .73 .70 .52
ATP .96 .78 .55 .46 .31 .33 .48
KLA/ATP .74 .64 .52 .42 .37 .36 .45
Ppp3cb
KLA  ATP  ATP+KLA
 AK135203 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720421K10 product:protein phosphatase 3, catalytic subunit, beta isoform, full insert sequence. [AK135203] KLA 1.74 1.57 1.91 1.59 1.47 1.26 1.40
ATP 1.17 1.03 1.30 1.00 .81 .62 1.37
KLA/ATP 1.68 1.70 1.91 1.37 1.09 .47 1.13
Ppp3cb
KLA  ATP  ATP+KLA
 AK171904 activated spleen cDNA, RIKEN full-length enriched library, clone:F830018L06 product:Protein phosphatase 3 catalytic subunit beta3 (EC 3.1.3.16) (Serine [AK171904] KLA 1.29 1.29 1.21 1.15 1.22 1.13 1.28
ATP .90 .86 .80 .98 .94 .73 .92
KLA/ATP 1.06 1.03 .77 1.04 .92 .68 .90
Ppp3cb
KLA  ATP  ATP+KLA
 NM_008914 protein phosphatase 3, catalytic subunit, beta isoform (Ppp3cb), mRNA [NM_008914] KLA 1.21 1.29 1.38 1.24 1.29 1.08 1.23
ATP 1.15 1.31 1.09 1.29 .86 .60 .64
KLA/ATP 1.33 1.40 1.04 1.28 .79 .58 .73
Ppp3cc
KLA  ATP  ATP+KLA
 AK037563 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130026K22 product:unclassifiable, full insert sequence [AK037563] KLA 1.27 1.18 1.21 1.15 1.01 .92 1.36
ATP .96 1.09 1.10 1.03 .85 1.06 1.47
KLA/ATP 1.17 1.24 1.07 1.13 .91 .88 1.36
Ppp3cc
KLA  ATP  ATP+KLA
 NM_008915 protein phosphatase 3, catalytic subunit, gamma isoform (Ppp3cc), mRNA [NM_008915] KLA 1.64 1.81 1.79 1.35 .90 .70 1.31
ATP .90 .90 1.13 .93 .86 1.40 1.60
KLA/ATP 1.45 1.62 1.74 1.47 1.04 1.01 1.31
Ppp3r1
KLA  ATP  ATP+KLA
 NM_024459 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) (Ppp3r1), mRNA [NM_024459] KLA 1.02 1.17 .93 1.27 1.15 1.30 1.30
ATP .97 .95 .77 .91 .99 1.18 1.10
KLA/ATP 1.12 1.04 .88 1.00 1.10 1.10 1.07
Ppp3r2
KLA  ATP  ATP+KLA
 NM_001004025 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type II) (Ppp3r2), mRNA [NM_001004025] KLA 1.03 1.05 1.06 1.08 1.12 1.05 1.04
ATP 1.00 1.02 1.04 1.04 .99 .99 1.01
KLA/ATP 1.04 1.12 1.03 1.09 1.00 .99 1.00
Rac1
KLA  ATP  ATP+KLA
 NM_009007 RAS-related C3 botulinum substrate 1 (Rac1), mRNA [NM_009007] KLA 1.02 1.01 1.02 .99 1.03 1.15 1.08
ATP .99 1.15 1.01 1.27 1.06 1.20 1.06
KLA/ATP 1.00 1.04 .88 1.16 .91 1.21 1.38
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Relb
KLA  ATP  ATP+KLA
 NM_009046 avian reticuloendotheliosis viral (v-rel) oncogene related B (Relb), mRNA [NM_009046] KLA 4.39 4.46 3.54 3.47 4.36 3.18 2.72
ATP 1.01 1.07 1.23 2.66 3.23 3.50 1.24
KLA/ATP 4.43 4.52 3.56 4.10 2.85 2.92 3.30
Sfpi1
KLA  ATP  ATP+KLA
 NM_011355 SFFV proviral integration 1 (Sfpi1), mRNA [NM_011355] KLA 2.54 2.77 2.96 2.31 3.22 2.44 2.29
ATP 1.17 1.55 .79 1.96 1.49 1.23 1.66
KLA/ATP 3.35 3.40 1.30 3.78 1.70 1.80 3.18
Sirpa
KLA  ATP  ATP+KLA
 NM_007547 signal-regulatory protein alpha (Sirpa), mRNA [NM_007547] KLA .58 .56 .55 .51 .73 1.13 1.19
ATP 1.03 1.10 .90 .84 .54 .45 1.08
KLA/ATP .62 .62 .44 .48 .40 .49 1.42
Sirpb1
KLA  ATP  ATP+KLA
 NM_001002898 signal-regulatory protein beta 1 (Sirpb1), transcript variant 3, mRNA [NM_001002898] KLA 1.42 1.48 2.48 3.40 5.19 7.61 15.34
ATP .97 .99 1.13 1.41 1.02 1.23 7.36
KLA/ATP 1.53 1.50 1.68 2.07 1.58 2.62 16.58
Socs1
KLA  ATP  ATP+KLA
 NM_009896 suppressor of cytokine signaling 1 (Socs1), mRNA [NM_009896] KLA 27.36 22.16 20.64 23.08 17.74 21.71 10.12
ATP .91 .72 2.03 12.69 9.16 19.87 6.80
KLA/ATP 26.70 24.56 28.15 31.28 26.32 29.95 22.51
Socs3
KLA  ATP  ATP+KLA
 NM_007707 suppressor of cytokine signaling 3 (Socs3), mRNA [NM_007707] KLA 7.56 6.68 6.29 7.36 6.47 7.03 5.33
ATP 1.51 1.75 4.63 6.27 6.92 7.74 4.64
KLA/ATP 6.82 6.77 9.19 8.32 9.51 8.98 8.33
Sqstm1
KLA  ATP  ATP+KLA
 NM_011018 sequestosome 1 (Sqstm1), mRNA [NM_011018] KLA 3.50 3.07 2.12 1.55 .75 1.00 2.24
ATP 1.03 .98 1.63 2.91 6.11 9.76 1.45
KLA/ATP 3.46 3.23 3.50 2.93 3.38 4.26 2.74
Stat1
KLA  ATP  ATP+KLA
 NM_009283 signal transducer and activator of transcription 1 (Stat1), mRNA [NM_009283] KLA 2.90 2.72 3.00 3.64 4.58 6.51 5.58
ATP 1.01 .92 .89 .72 .51 2.22 3.07
KLA/ATP 2.73 2.65 2.34 1.95 1.99 4.70 8.66
Stat2
KLA  ATP  ATP+KLA
 NM_019963 signal transducer and activator of transcription 2 (Stat2), mRNA [NM_019963] KLA 5.64 4.80 4.99 6.48 6.28 9.50 5.36
ATP .90 .80 1.03 .66 .97 4.90 4.07
KLA/ATP 4.47 4.88 6.34 4.27 6.76 9.49 11.43
Syk
KLA  ATP  ATP+KLA
 NM_011518 spleen tyrosine kinase (Syk), mRNA [NM_011518] KLA 2.48 2.59 2.57 2.26 3.29 3.75 3.19
ATP .96 .85 .59 1.01 2.80 3.77 2.11
KLA/ATP 2.56 2.09 1.16 1.35 2.50 4.33 5.10
Tec
KLA  ATP  ATP+KLA
 NM_001113460 cytoplasmic tyrosine kinase, Dscr28C related (Drosophila) (Tec), transcript variant 1, mRNA [NM_001113460] KLA .41 .41 .51 .46 .47 .83 .68
ATP .94 .91 .87 1.00 1.05 .71 1.42
KLA/ATP .43 .42 .43 .38 .54 .93 1.46
Tgfb1
KLA  ATP  ATP+KLA
 NM_011577 transforming growth factor, beta 1 (Tgfb1), mRNA [NM_011577] KLA .87 .89 .90 .70 .83 .77 1.12
ATP 1.20 1.41 .80 1.49 1.11 .93 .99
KLA/ATP 1.10 1.20 .53 1.05 .66 .85 .90
Tgfb2
KLA  ATP  ATP+KLA
 NM_009367 transforming growth factor, beta 2 (Tgfb2), mRNA [NM_009367] KLA 1.01 .91 .98 .98 .92 1.19 .96
ATP .99 1.03 1.00 1.02 .99 1.07 .93
KLA/ATP 1.02 .99 1.03 .98 1.04 1.06 .96
Tgfbr1
KLA  ATP  ATP+KLA
 NM_009370 transforming growth factor, beta receptor I (Tgfbr1), mRNA [NM_009370] KLA .73 .74 .59 .54 .52 .64 .84
ATP .99 1.12 .99 1.16 1.22 .84 .93
KLA/ATP .75 .78 .58 .64 .62 .59 .77
Tgfbr2
KLA  ATP  ATP+KLA
 AK090393 10 days pregnant adult female ovary and uterus cDNA, RIKEN full-length enriched library, clone:G630098D03 product:transforming growth factor, beta receptor II, full insert sequence. [AK090393] KLA .98 .89 1.00 .96 .94 1.00 .92
ATP .99 .99 .90 .94 .93 .96 1.02
KLA/ATP .92 .96 .98 .98 .98 .95 1.01
Tgfbr2
KLA  ATP  ATP+KLA
 NM_009371 transforming growth factor, beta receptor II (Tgfbr2), transcript variant 1, mRNA [NM_009371] KLA .55 .50 .58 .50 .52 .55 .44
ATP .98 .75 .50 .32 .41 .29 .50
KLA/ATP .59 .45 .32 .23 .31 .27 .25
Tgfbr2
KLA  ATP  ATP+KLA
 NM_029575 transforming growth factor, beta receptor II (Tgfbr2), transcript variant 2, mRNA [NM_029575] KLA .95 .93 .99 .95 .88 1.02 .82
ATP .87 .93 .84 .84 .74 .72 1.00
KLA/ATP .89 .85 .83 .85 .76 .80 .79
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Tnfrsf11
a
KLA  ATP  ATP+KLA
 NM_009399 tumor necrosis factor receptor superfamily, member 11a (Tnfrsf11a), mRNA [NM_009399] KLA 1.43 1.33 1.36 1.58 1.87 1.83 1.47
ATP 1.07 1.17 1.02 1.19 .95 .82 1.13
KLA/ATP 1.55 1.46 1.16 1.46 .79 .95 1.92
Tnfrsf11
b
KLA  ATP  ATP+KLA
 NM_008764 tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) (Tnfrsf11b), mRNA [NM_008764] KLA 1.00 .98 .98 .98 1.02 .94 .90
ATP .99 .98 1.06 .97 .94 .99 .98
KLA/ATP .97 1.04 1.09 .94 .95 .92 1.01
Tnfrsf1a
KLA  ATP  ATP+KLA
 NM_011609 tumor necrosis factor receptor superfamily, member 1a (Tnfrsf1a), mRNA [NM_011609] KLA 1.74 1.71 1.90 2.16 1.95 1.74 1.16
ATP .95 .83 .55 .41 .41 1.55 1.32
KLA/ATP 1.58 1.49 1.19 1.03 .98 2.02 2.10
Tnfsf11
KLA  ATP  ATP+KLA
 NM_011613 tumor necrosis factor (ligand) superfamily, member 11 (Tnfsf11), mRNA [NM_011613] KLA 1.00 1.00 1.08 .96 .97 1.01 .96
ATP 1.01 1.05 .97 .86 1.05 1.03 1.01
KLA/ATP 1.04 1.05 .99 1.04 1.01 1.02 .99
Traf2
KLA  ATP  ATP+KLA
 NM_009422 Tnf receptor-associated factor 2 (Traf2), mRNA [NM_009422] KLA 3.38 3.62 3.49 3.36 3.49 3.39 2.68
ATP .97 1.04 1.00 1.10 1.54 2.40 1.55
KLA/ATP 3.38 3.16 2.93 2.74 2.67 3.11 4.70
Traf6
KLA  ATP  ATP+KLA
 NM_009424 Tnf receptor-associated factor 6 (Traf6), mRNA [NM_009424] KLA 1.19 1.28 1.34 1.20 1.23 1.23 1.28
ATP 1.06 1.12 .92 1.15 2.46 1.84 1.40
KLA/ATP 1.32 1.37 .89 1.16 1.45 1.49 1.46
Trem2
KLA  ATP  ATP+KLA
 NM_031254 triggering receptor expressed on myeloid cells 2 (Trem2), mRNA [NM_031254] KLA .65 .62 .56 .57 .48 .38 .20
ATP .97 .98 .89 .88 .75 .70 .77
KLA/ATP .66 .64 .62 .62 .49 .44 .53
Tyk2
KLA  ATP  ATP+KLA
 NM_018793 tyrosine kinase 2 (Tyk2), mRNA [NM_018793] KLA 2.91 2.95 3.42 3.26 3.85 2.35 1.42
ATP 1.09 1.01 .68 .64 .59 .86 1.10
KLA/ATP 2.95 3.04 2.23 1.82 1.24 1.27 2.09
Tyrobp
KLA  ATP  ATP+KLA
 NM_011662 TYRO protein tyrosine kinase binding protein (Tyrobp), mRNA [NM_011662] KLA .80 .78 .84 .69 .72 .69 .92
ATP 1.10 1.12 .90 1.11 .83 .71 .90
KLA/ATP .92 .90 .64 .87 .65 .61 .92